Waterloo, Ontario, Canada-based Nuro’s Kompos II keyboard features 44 keys, controllable instantly by thought. The company believes the system can cater to a range of computing needs and industries, but it has uses in a medical sense. Nuro implemented Kompos II with fully locked-in juvenile and adult patients, plus victims of trauma, stroke, infections or neurodegenerative diseases.
Individuals no longer able to use eye gaze technology can use this system to communicate. The company offers Kompos II as a complimentary upgrade for all Nuro customers worldwide.
“We foresee the ramifications of Kompos II to be absolutely massive in healthcare and in environments where traditional typing and communication with others is a difficult or an impossible task,” said Francois Gand, founder and CEO of Nuro.
Dr. David Putrino, director of rehabilitation innovation for the Mount Sinai Health System (New York), works with a Nuro patient. Putrino said that the user of the technology regained their ability to type “under complete cognitive control.”
“This level of cognitive control of a digital device was previously not possible using any other technological interface,” Putrino said. “The newfound freedom that this user has experienced has touched not only her and her parents, but also many of the clinicians who are involved in her professional care and rehabilitation. I want to extend my heartfelt thanks to Nuro and its dedicated team for making this profound impact possible.”
